The Cxbladder test report provides actionable results that are intended to aid in the risk stratification of urothelial cancer when used in conjunction with standard clinical assessment.
The report have been developed in consultation with leading urologists and provides a patient’s validated Cxbladder score, alongside an interpretation of the results and an assay description.
Cxbladder Triage Plus Results Interpretation
The Cxbladder Triage score ranges from 0.0 to 1.0.
LOW Probability (< 0.15): An NPV of 99.4% for scores <0.15. Low probability of UC.
INTERMEDIATE Probability (0.15 ≤ score < 0.54): A sensitivity of 93.6% and a specificity of 90.8% for scores ≥ 0.15 and < 0.54. Increased probability of UC.
HIGH Probability (≥ 0.54): A PPV of 74.6% for scores > 0.54 with a specificity of 98.2% in the validation cohort. High probability of UC.
Cxbladder Triage Results Interpretation
The Cxbladder Triage score ranges from 0.0 to 10.0. Using a cut-off of 4.0, it identifies patients who have a low probability of having UC.
Cxbladder Monitor Results Interpretation
A Cxbladder Monitor score of <3.5 has a Negative Predictive Value (NPV) of 97%, and sensitivity of 93%. This indicates a low probability of recurrent UC.
A Cxbladder Monitor score of ≥ 3.5 indicates that a clinician-directed protocol to determine the presence of recurrent UC, is warranted.
The report tracks Cxbladder Monitor scores over time.
Last Updated: 27 Jul 2026 02:44 pm
